Literature DB >> 19269036

Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?

Lucile Capuron1, Fiona B Fornwalt, Bettina T Knight, Philip D Harvey, Philip T Ninan, Andrew H Miller.   

Abstract

BACKGROUND: Cytokines of the innate immune response may contribute to behavioral alterations that resemble major depression as manifested in medically healthy individuals.
METHODS: To explore potential similarities and differences between cytokine-induced depression and idiopathic major depression in healthy subjects, dimensional analyses comparing specific symptom dimensions of depression were conducted in 20 patients with malignant melanoma administered the innate immune cytokine, interferon (IFN)-alpha, and 28 medically healthy subjects with major depression of similar age and gender distribution. The Hamilton Rating Scale for Depression was used to assess severity of individual depressive symptoms.
RESULTS: Severity of symptoms of anxiety, depressed mood, and impaired work/activities were comparable between patients with IFN-alpha-induced depression and medically healthy depressed patients. Interestingly, however, compared to medically healthy patients with major depression, patients with IFN-alpha-induced depression reported significantly greater psychomotor retardation and weight loss and significantly less severe feelings of guilt. LIMITATIONS: The relatively small sample size limited statistical power to detect small differences in symptom expression among groups.
CONCLUSIONS: The data suggest that there is considerable overlap in symptom expression between cytokine-induced depression and idiopathic depression in medically healthy subjects. Nevertheless, differences in isolated symptom domains suggest that cytokines may preferentially target neurocircuits relevant to psychomotor activity (e.g. basal ganglia), while having a limited effect on cognitive distortions regarding self-appraisal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269036      PMCID: PMC2763953          DOI: 10.1016/j.jad.2009.02.017

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  23 in total

1.  Paroxetine for the prevention of depression induced by high-dose interferon alfa.

Authors:  D L Musselman; D H Lawson; J F Gumnick; A K Manatunga; S Penna; R S Goodkin; K Greiner; C B Nemeroff; A H Miller
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 3.  Cytokines and anorexia: a brief overview.

Authors:  C R Plata-Salamán
Journal:  Semin Oncol       Date:  1998-02       Impact factor: 4.929

4.  Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome.

Authors:  K Kroenke; J L Jackson; J Chamberlin
Journal:  Am J Med       Date:  1997-11       Impact factor: 4.965

5.  An international study of the relation between somatic symptoms and depression.

Authors:  G E Simon; M VonKorff; M Piccinelli; C Fullerton; J Ormel
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

6.  Prefrontal cortical hypometabolism during low-dose interferon alpha treatment.

Authors:  F D Juengling; D Ebert; O Gut; M A Engelbrecht; J Rasenack; E U Nitzsche; J Bauer; K Lieb
Journal:  Psychopharmacology (Berl)       Date:  2000-11       Impact factor: 4.530

7.  Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.

Authors:  L Capuron; A Ravaud; R Dantzer
Journal:  Psychosom Med       Date:  2001 May-Jun       Impact factor: 4.312

8.  Cytokine-associated emotional and cognitive disturbances in humans.

Authors:  A Reichenberg; R Yirmiya; A Schuld; T Kraus; M Haack; A Morag; T Pollmächer
Journal:  Arch Gen Psychiatry       Date:  2001-05

Review 9.  Depression and pain comorbidity: a literature review.

Authors:  Matthew J Bair; Rebecca L Robinson; Wayne Katon; Kurt Kroenke
Journal:  Arch Intern Med       Date:  2003-11-10

10.  Endotoxin produces a depressive-like episode in rats.

Authors:  R Yirmiya
Journal:  Brain Res       Date:  1996-03-04       Impact factor: 3.252

View more
  63 in total

1.  Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.

Authors:  Karina W Davidson; Matthew M Burg; Ian M Kronish; Daichi Shimbo; Lucia Dettenborn; Roxana Mehran; David Vorchheimer; Lynn Clemow; Joseph E Schwartz; Francois Lespérance; Nina Rieckmann
Journal:  Arch Gen Psychiatry       Date:  2010-05

Review 2.  A critical review of human endotoxin administration as an experimental paradigm of depression.

Authors:  Nicole DellaGioia; Jonas Hannestad
Journal:  Neurosci Biobehav Rev       Date:  2009-08-08       Impact factor: 8.989

Review 3.  Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Authors:  Jennifer M Loftis; Marilyn Huckans; Benjamin J Morasco
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

Review 4.  Inflammation in neurological and psychiatric diseases.

Authors:  Parto S Khansari; Beata Sperlagh
Journal:  Inflammopharmacology       Date:  2012-02-24       Impact factor: 4.473

5.  Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.

Authors:  Jennifer C Felger; Li Li; Paul J Marvar; Bobbi J Woolwine; David G Harrison; Charles L Raison; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2012-10-13       Impact factor: 7.217

Review 6.  Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

Authors:  Jennifer C Felger; Andrew H Miller
Journal:  Front Neuroendocrinol       Date:  2012-09-21       Impact factor: 8.606

Review 7.  Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction.

Authors:  Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 8.  Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology.

Authors:  Lisa M Jaremka; Monica E Lindgren; Janice K Kiecolt-Glaser
Journal:  Depress Anxiety       Date:  2013-02-14       Impact factor: 6.505

9.  Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients.

Authors:  Masatoshi Inagaki; Tatsuo Akechi; Toru Okuyama; Yuriko Sugawara; Hiroya Kinoshita; Yasuo Shima; Kimio Terao; Shuichi Mitsunaga; Atsushi Ochiai; Yosuke Uchitomi
Journal:  Support Care Cancer       Date:  2013-02-28       Impact factor: 3.603

10.  CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.

Authors:  C L Raison; R Dantzer; K W Kelley; M A Lawson; B J Woolwine; G Vogt; J R Spivey; K Saito; A H Miller
Journal:  Mol Psychiatry       Date:  2009-11-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.